Repare Therapeutics Inc.
RPTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $73 | $68 | $84 | $85 |
| Short-Term Investments | $40 | $42 | $40 | $68 |
| Receivables | $6 | $15 | $12 | $12 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $2 | $5 | $6 |
| Total Curr. Assets | $124 | $127 | $140 | $171 |
| Property Plant & Equip (Net) | $0 | $1 | $2 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2 | $2 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $2 | $1 | $1 |
| Total NC Assets | $2 | $4 | $4 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $127 | $130 | $144 | $177 |
| Liabilities | – | – | – | – |
| Payables | $1 | $4 | $2 | $4 |
| Short-Term Debt | $0 | $1 | $1 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $10 | $15 | $15 | $20 |
| Total Curr. Liab. | $12 | $20 | $19 | $25 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $1 | $2 |
| Total Liabilities | $12 | $20 | $19 | $25 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $490 | $490 | $490 | $487 |
| Retained Earnings | -$461 | -$465 | -$448 | -$418 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $86 | $85 | $83 | $82 |
| Total Equity | $115 | $110 | $125 | $151 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $127 | $130 | $144 | $177 |
| Net Debt | -$72 | -$67 | -$83 | -$83 |